See the
full picture
with Perimeter.

The Time to Know is Now

Perimeter OCT Margin Imaging Technology

Re-excision surgeries due to positive margins are all too common. Surgeons need to know whether they have achieved clean margins during the initial surgery.

Harnessing the power of advanced technology, Perimeter Medical Imaging is driven to transform cancer surgery with advanced imaging tools. The Perimeter Optical Coherence Tomography (OCT) system provides high-resolution imaging to help cancer1 surgeons get clean margins in real time – when it matters most.

See the Benefits

The S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. More information here.

With Perimeter's OCT technology, breast surgeons have a much better chance of getting clean margins the first time we do a lumpectomy.

Michele Carpenter, MD, FACS

I believe this technology represents the next standard of care in cancer surgery.

Amelia Tower, DO

Perimeter’s OCT technology has become integral in providing the best possible care to my patients.

Amelia Gunter, MD

OCT has helped direct my excision of shaved margins in the OR.

Beth Anglin, MD, FACS

In the OR, OCT provides ultra-high resolution visualization of my specimen. This adds to my confidence on the final margin status.

Beth DuPree, MD, FACS, ABOIM

I believe that this technology is the next giant leap in margin visualization.

Shawndeep S. Tung, MD

The S-Series OCT has a general indication and has not been evaluated by FDA for specific uses. More information here.

WEBINAR PLAYBACK: Reoperation Realities in Breast Cancer Care: Cost, Complications, and Impact on Patients and Healthcare Systems

Discover the latest insights from a peer-reviewed study conducted by physicians at MD Anderson and UT Health Houston. In this webinar, Drs. Nina Tamirisa and Ted James dive into the critical issue of reoperations after breast-conserving surgery and strategies to reduce reoperations.

Featured

News
Perimeter announces results from a peer-reviewed study, which highlights the clinical viability of AI-enhanced margin visualization using WF-OCT in breast cancer surgery and its potential to decrease re-operation rates due to residual tumors.
WHITE PAPER
This paper comprehensively analyzes current reoperation rates for breast-conserving surgery patients and their associated implications, underscoring the need for new strategies and technologies to address this problem.
Case Study
Breast cancer surgeon, Dr. Beth DuPree, explains the benefits of using Perimeter's S-Series OCT technology in the OR.
Patient Story
Nadia shares her journey with breast cancer and infertility, as well as her treatment plan with Perimeter's technology.
Case Study
Dr. Amelia Tower, breast surgical oncologist, describes how she used Perimeter’s OCT imaging in the OR to evaluate tissue microstructures and identify regions of concern that were not detected with specimen radiography.
Conference Presentation
Hear breast cancer surgeons, Dr. Shawndeep S. Tung, MemorialCare Cancer Institute, and Dr. Nina Tamirisa, MD Anderson Cancer Center, discuss how OCT gives surgeons actionable insights on their patients’ margins in the operating room.
Webinar Replay
Getting clean margins remains a challenge for surgeons. Hear from breast surgeons Dr. Michele Carpenter, who described OCT as “like having a pathology slide in the OR,” and Dr. Beth DuPree, an early OCT user.
Clinical Paper
This study's findings suggest that WF-OCT may be a promising imaging modality for intraoperative analysis in head and neck surgery, especially at deep margins, without impacting specimen integrity or surgical and pathology workflows.
View All

Ready to connect with
Perimeter?

Get Started

Continue Exploring

Products

Benefits to Surgeons

See It In Action

Ready to learn more about Perimeter?

Get Started